Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,409 | 381 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,165 | 81 | $0 (2024) |
| ABBVIE INC. | $504.74 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $336.13 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $318.64 | 18 | $0 (2024) |
| PFIZER INC. | $298.97 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $280.76 | 17 | $0 (2024) |
| Abbott Laboratories | $257.85 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $257.07 | 17 | $0 (2023) |
| Lilly USA, LLC | $250.59 | 13 | $0 (2024) |
| Amgen Inc. | $211.11 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,010 | 56 | Novo Nordisk Inc ($145.85) |
| 2023 | $1,735 | 92 | Novo Nordisk Inc ($326.54) |
| 2022 | $1,576 | 95 | Novo Nordisk Inc ($343.66) |
| 2021 | $2,088 | 138 | Novo Nordisk Inc ($348.66) |
All Payment Transactions
381 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Cardio-renal | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.25 | General |
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Obesity | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Vaccines | ||||||
| 06/13/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/29/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Biological | ||||||
| 05/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.57 | General |
| Category: NEUROLOGY | ||||||
| 04/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 322 | 465 | $94,218 | $14,481 |
| 2022 | 9 | 356 | 521 | $93,269 | $17,891 |
| 2021 | 11 | 352 | 541 | $101,451 | $17,619 |
| 2020 | 14 | 442 | 661 | $112,443 | $21,097 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 115 | $35,549 | $4,447 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 115 | $24,416 | $4,378 | 17.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 32 | 36 | $2,803 | $1,246 | 44.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 32 | 72 | $5,363 | $1,168 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $6,078 | $1,061 | 17.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $13,801 | $741.04 | 5.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 30 | 34 | $2,390 | $550.80 | 23.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $2,041 | $515.32 | 25.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 19 | 19 | $1,543 | $336.11 | 21.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 17 | $234.09 | $37.40 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 198 | $40,701 | $8,055 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 97 | $29,461 | $4,690 | 15.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 38 | 42 | $2,952 | $1,467 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $8,325 | $1,169 | 14.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 23 | 46 | $3,233 | $747.42 | 23.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 40 | 45 | $3,163 | $733.27 | 23.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 24 | 28 | $3,948 | $611.46 | 15.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 20 | 20 | $1,100 | $355.96 | 32.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 28 | $385.56 | $61.89 | 16.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 196 | $40,290 | $7,633 | 18.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 99 | $30,068 | $4,488 | 14.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 30 | 30 | $14,847 | $1,887 | 12.7% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 25 | 30 | $2,109 | $1,060 | 50.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 16 | 25 | $3,525 | $813.41 | 23.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 24 | 24 | $1,320 | $433.20 | 32.8% |
About Jenna Gunselman, PA
Jenna Gunselman, PA is a Physician Assistant healthcare provider based in Gallatin, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1538523162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenna Gunselman, PA has received a total of $6,409 in payments from pharmaceutical and medical device companies, with $1,010 received in 2024. These payments were reported across 381 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,409).
As a Medicare-enrolled provider, Gunselman has provided services to 1,472 Medicare beneficiaries, totaling 2,188 services with total Medicare billing of $71,088. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Gallatin, TN
- Active Since 04/10/2016
- Last Updated 02/16/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538523162
Products in Payments
- Ozempic (Drug) $637.99
- Rybelsus (Drug) $347.84
- NURTEC ODT (Drug) $289.84
- VRAYLAR (Drug) $282.49
- ENTRESTO (Drug) $236.73
- TRELEGY ELLIPTA (Drug) $195.94
- Vascepa (Drug) $181.23
- UBRELVY (Drug) $175.23
- FREESTYLE LIBRE 3 (Device) $156.40
- REXULTI (Drug) $152.47
- PREMARIN (Drug) $149.29
- AUSTEDO (Drug) $144.80
- XARELTO (Drug) $144.08
- Omnipod (Device) $141.45
- XIFAXAN (Drug) $140.81
- MOUNJARO (Drug) $135.73
- BREZTRI (Drug) $128.75
- TRINTELLIX (Drug) $123.07
- JARDIANCE (Drug) $101.53
- LEQVIO (Drug) $99.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Gallatin
Madison Webb, Pa-C, PA-C
Physician Assistant — Payments: $32,146
Mrs. Ellen Meador, Pa, PA
Physician Assistant — Payments: $6,607
Mrs. Kaylee Mayberry, Pa-C, PA-C
Physician Assistant — Payments: $2,354
Mrs. Andrea Martin-Willie, Pa-C, PA-C
Physician Assistant — Payments: $2,301
Mrs. Jennifer Brewer, Pa-C, PA-C
Physician Assistant — Payments: $1,998
Ilysa Bartol, Pa-C, PA-C
Physician Assistant — Payments: $1,694